Adenoviral vaccine targeting multiple neoantigens as strategy to eradicate large tumors combined with checkpoint blockade
Vaccination against neo-antigens has resulted in an effective antitumor response in several models. Here, the authors show that delivery of larger sets of neo-antigens using an adenovirus-based vaccination platform, results in much better tumor protection when combined with checkpoint blockade in a...
Guardado en:
Autores principales: | Anna Morena D’Alise, Guido Leoni, Gabriella Cotugno, Fulvia Troise, Francesca Langone, Imma Fichera, Maria De Lucia, Lidia Avalle, Rosa Vitale, Adriano Leuzzi, Veronica Bignone, Elena Di Matteo, Fabio Giovanni Tucci, Valeria Poli, Armin Lahm, Maria Teresa Catanese, Antonella Folgori, Stefano Colloca, Alfredo Nicosia, Elisa Scarselli |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/db93e80d193c417e9e00b2880fe30cbc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Novel Human Anti-PD-L1 mAbs Inhibit Immune-Independent Tumor Cell Growth and PD-L1 Associated Intracellular Signalling
por: Margherita Passariello, et al.
Publicado: (2019) -
Management of Adenoviral Keratoconjunctivitis: Challenges and Solutions
por: Labib BA, et al.
Publicado: (2020) -
EPIDEMIOLOGY OF ADENOVIRAL INFECTION IN ST. PETERSBURG
por: I. V. Ovsyannikova, et al.
Publicado: (2018) -
Neoantigens elicit T cell responses in breast cancer
por: Takafumi Morisaki, et al.
Publicado: (2021) -
Protein citrullination as a source of cancer neoantigens
por: Makoto Kobayashi, et al.
Publicado: (2021)